Methylbenactyzium Bromide

Methylbenactyzium Bromide is a muscarinic acetylcholine receptor (mAChR) inhibitor.

Product Specifications

CAS Number

[3166-62-9]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

MAChR

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Methylbenactyzium_Bromide.html

Concentration

10mM

Purity

99.53

Solubility

DMSO : 6 mg/mL (ultrasonic; warming) |H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(OCC[N+](CC)(CC)C)C(C1=CC=CC=C1)(O)C2=CC=CC=C2.[Br-]

Molecular Formula

C21H28BrNO3

Molecular Weight

422.36

Precautions

H302, H315, H319, H335

References & Citations

[1]Bhattacharjee AK, et al. Discovery of subtype selective muscarinic receptor antagonists as alternatives to atropine using in silico pharmacophore modeling and virtual screening methods. Bioorg Med Chem. 2013 May 1;21 (9) :2651-62.|[2]Nishikawa M, et al. Analysis of methylbenactyzium bromide in human urine by thin-layer chromatography and pyrolysis gas chromatography. Forensic Sci Int. 1991 Mar;49 (2) :197-203.